[New aspects in the treatment of acute cardiac insufficiency].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004329:Droperidol / Q000627:therapeutic use; D005283:Fentanyl / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D007548:Isosorbide Dinitrate / Q000627:therapeutic use; D008833:Microcirculation / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects*; D009458:Neuroleptanalgesia; D009599:Nitroprusside / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D012121:Respiration, Artificial; D014655:Vascular Resistance / Q000187:drug effects*; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides; D004232:Diuretics; D005343:Fibrinolytic Agents; D014665:Vasodilator Agents; D009599:Nitroprusside; D006830:Hydralazine; D007548:Isosorbide Dinitrate; D003000:Clonidine; D003981:Diazoxide; D004329:Droperidol; D005283:Fentanyl; D011224:Prazosin; D010646:Phentolamine
Neue Aspekte bei der Behandlung der akuten Herzinsuffizienz.